Royalty Pharma plc
RPRX
41 insider filings · Latest: Aug 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Aug 17 9:01 PM | Terrance P. CoyneEVP & CFO | Sale | 11,002 | $58.68 | $645.6K | 0(I) | View → |
| Aug 13, 2026 | Aug 13 8:43 PM | Terrance Coyne | Proposed Sale | 11,002 | $58.56 | $644.3K | — | View → |
| Aug 12, 2026 | Aug 12 10:32 PM | Errol B. De Souza | Proposed Sale | 206,352 | $57.79 | $11.9M | — | View → |
| Aug 12, 2026 | Aug 12 10:28 PM | Errol B. De Souza | Proposed Sale | 125,000 | $57.79 | $7.2M | — | View → |
| Jul 1, 2026 | Jul 2 8:10 PM | Marshall UristEVP, Research & Investments | Sale | 9,099 | $55.88 | $508.5K | 0(D) | View → |
| Jun 30, 2026 | Jul 2 8:08 PM | Christopher HiteEVP & Chairman, Partnering | Sale | 130,000 | $56.50 | $7.3M | 40,000(I) | View → |
| Jul 1, 2026 | Jul 1 8:18 PM | Urist Marshall | Proposed Sale | 9,099 | $55.88 | $508.5K | — | View → |
| Jun 30, 2026 | Jul 1 12:24 PM | SCH Investment Partners LLC | Proposed Sale | 100,000 | $57.09 | $5.7M | — | View → |
| Jun 24, 2026 | Jun 25 9:13 PM | Marshall UristEVP, Research & Investments | Sale | 9,098 | $55.18 | $502.1K | 9,099(D) | View → |
| Jun 23, 2026 | Jun 25 9:11 PM | Christopher HiteEVP & Chairman, Partnering | Sale | 150,000 | $54.40 | $8.2M | 559,399(I) | View → |
| Jun 24, 2026 | Jun 24 8:14 PM | Urist Marshall | Proposed Sale | 9,098 | $55.18 | $502.1K | — | View → |
| Jun 23, 2026 | Jun 23 8:48 PM | Christopher Hite | Proposed Sale | 30,000 | $55.35 | $1.7M | — | View → |
| Jun 23, 2026 | Jun 23 8:46 PM | SCH Investment Partners LLC | Proposed Sale | 150,000 | $54.45 | $8.2M | — | View → |
| May 26, 2026 | May 28 8:48 PM | Terrance P. CoyneEVP & CFO | Sale | 64,399 | $53.98 | $3.5M | 0(I) | View → |
| May 26, 2026 | May 26 9:49 PM | Terrance Coyne | Proposed Sale | 64,399 | $53.86 | $3.5M | — | View → |
| May 20, 2026 | May 22 1:20 AM | Marshall UristEVP, Research & Investments | Sale | 13,684 | $52.75 | $721.8K | 18,197(D) | View → |
| May 20, 2026 | May 20 8:23 PM | Urist Marshall | Proposed Sale | 13,684 | $52.75 | $721.8K | — | View → |
| May 14, 2026 | May 15 8:38 PM | Marshall UristEVP, Research & Investments | Sale | 13,684 | $53.06 | $726.1K | 31,881(D) | View → |
| May 14, 2026 | May 15 8:37 PM | Gregory NordenDirector | Sale | 3,045 | $53.00 | $161.4K | 191,803(D) | View → |
| May 14, 2026 | May 14 9:28 PM | Norden Gregory | Proposed Sale | 3,045 | $53.00 | $161.4K | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Aug 7 9:24 PM | Pablo G. LegorretaDirector, CEO, Chairman of the Board | Gift | 30,000 | — | 662,701(D) | View → |
| Aug 7, 2026 | Aug 7 9:24 PM | Terrance P. CoyneEVP & CFO | Gift | 18,500 | — | 1,788,777(I) | View → |
| Aug 7, 2026 | Aug 7 9:11 PM | Marshall UristEVP, Research & Investments | Gift | 3,000 | — | 244,412(I) | View → |